MHC-II+ G-MDSC expressing CD80, CD86, or ICOSL are associated with pro-inflammatory CD4+ T cells phenotypes in the lungs of lupus-prone mice
Systemic lupus erythematosus (SLE) is a chronic inflammatory autoimmune disease that affects various tissues of the body. One of these tissues is the lung, in which pleuropulmonary manifestations commonly occur. In these patients, homeostasis is disrupted, characterized by a decrease in T reg and an increase in T h1 and T h2 cells. Myeloid-derived suppressor cells (MDSCs) are a cell population characterized by their ability to suppress the T cell response; however, in recent years, the presence of major histocompatibility complex class II (MHC-II) molecules on MDSCs has been reported. Nevertheless, the presence of costimulatory molecules, such as CD80, CD86, and ICOSL, has not been studied yet in MDSCs expressing MHC-II in the context of SLE. In this study, we evaluated the pulmonary microenvironment in SLE mice from an immunological and histological perspective. We observed increased pro-inflammatory cytokines and cellular infiltration in lungs of SLE mice. We also observed MDSC MHC-II cells expressing CD80, CD86, and ICOSL in this tissue, along with alterations of CD4 + T cells subsets, characterized by a decrease in IL-10 frequency in SLE mice. Moreover, we observed that G-MDSCs MHC-II expressing CD80, CD86, or ICOSL correlate positively with phenotypes of CD4 + T cells that produce IL-17 and IFN-γ. For this reason, we suggest that MHC-II + G-MDSC cells may contribute to an inflammatory environment that triggers tissue damage in the lungs of SLE mice.
Authors
- Abel Eduardo Vasquez (ORCID: https://orcid.org/0000-0001-7346-9043)
- Felipe Melo-González (ORCID: https://orcid.org/0000-0002-3711-2407)
- Felipe Simón (ORCID: https://orcid.org/0000-0002-2653-9798)
- Juan Pablo Mackern‐Oberti (ORCID: https://orcid.org/0000-0001-9437-0579)
- Rodolfo Paredes (ORCID: https://orcid.org/0000-0002-5909-9362)
- Katina Schinnerling (ORCID: https://orcid.org/0000-0003-2669-9764)
- Jorge A. Soto (ORCID: https://orcid.org/0000-0003-0335-9759)
- Felipe R. Uribe (ORCID: https://orcid.org/0009-0007-4695-0107)
- Sebastián A. Echeverría-Araya (ORCID: https://orcid.org/0000-0002-9911-7035)
- Alison Sepúlveda-Pontigo (ORCID: https://orcid.org/0009-0006-8219-9798)
- Grabiel J García-Velázquez (ORCID: https://orcid.org/0000-0002-7096-5938)
- Karissa Chávez (ORCID: https://orcid.org/0009-0008-0425-0812)
- Valeria Salazar-Montoya (ORCID: https://orcid.org/0009-0007-9940-4329)
- Benjamín Díaz-López
- Jocelyn Tobar
- Karen Bohmwald
Institutions
- Universidad Mayor (CL)
- Universidad Andrés Bello (CL)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Universidad Nacional de Cuyo (AR)
- Universidad Autónoma de Chile (CL)
- Universidad Andrés Bello (CL)
- Universidad Dr. Andrés Bello (SV)
- Instituto de Medicina y Biología Experimental de Cuyo (AR)
- Millennium Institute on Immunology and Immunotherapy (CL)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-10-26
- DOI
- https://doi.org/10.3389/fimmu.2026.1891967
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00